From the Departments of Epidemiology (H.I.Z., M.A.I., A.H., O.H.F., M.W.V.), Radiology and Nuclear Medicine (H.I.Z., M.A.I., W.J.N., A.v.d.L., G.P.K., M.W.V.), Neurology (M.A.I.), and Medical Informatics (W.J.N.), Erasmus MC, University Medical Center Rotterdam, Room Na28-18, PO Box 2040, 3000 CA Rotterdam, the Netherlands; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Mass (A.H.); and Department of Imaging Physics, Faculty of Applied Sciences, Delft University of Technology, Delft, the Netherlands (W.J.N.).
Radiology. 2017 Apr;283(1):205-214. doi: 10.1148/radiol.2016160548. Epub 2016 Dec 7.
Purpose To investigate the association between N-terminal pro-B-type natriuretic peptide (NT-proBNP), which is a marker of heart disease, and markers of subclinical brain damage on magnetic resonance (MR) images in community-dwelling middle-aged and elderly subjects without dementia and without a clinical diagnosis of heart disease. Materials and Methods This prospective population-based cohort study was approved by a medical ethics committee overseen by the national government, and all participants gave written informed consent. Serum levels of NT-proBNP were measured in 2397 participants without dementia or stroke (mean age, 56.6 years; age range, 45.7-87.3 years) and without clinical diagnosis of heart disease who were drawn from the population-based Rotterdam Study. All participants were examined with a 1.5-T MR imager. Multivariable linear and logistic regression analyses were used to investigate the association between NT-proBNP level and MR imaging markers of subclinical brain damage, including volumetric, focal, and microstructural markers. Results A higher NT-proBNP level was associated with smaller total brain volume (mean difference in z score per standard deviation increase in NT-proBNP level, -0.021; 95% confidence interval [CI]: -0.034, -0.007; P = .003) and was predominantly driven by gray matter volume (mean difference in z score per standard deviation increase in NT-proBNP level, -0.037; 95% CI: -0.057, -0.017; P < .001). Higher NT-proBNP level was associated with larger white matter lesion volume (mean difference in z score per standard deviation increase in NT-proBNP level, 0.090; 95% CI: 0.051, 0.129; P < .001), with lower fractional anisotropy (mean difference in z score per standard deviation increase in NT-proBNP level, -0.048; 95% CI: -0.088, -0.008; P = .019) and higher mean diffusivity (mean difference in z score per standard deviation increase in NT-proBNP level, 0.054; 95% CI: 0.018, 0.091; P = .004) of normal-appearing white matter. Conclusion In community-dwelling persons, higher serum NT-proBNP levels are associated with volumetric and microstructural MR imaging markers of subclinical brain damage. RSNA, 2016 Online supplemental material is available for this article.
目的 研究 N 端脑利钠肽前体(NT-proBNP)与磁共振(MR)图像上无症状性脑损伤标志物之间的相关性,NT-proBNP 是心脏病的标志物,研究对象为无痴呆且无心脏病临床诊断的社区居住的中老年人群。
材料与方法 本前瞻性基于人群的队列研究得到了国家政府监督的医学伦理委员会的批准,所有参与者均签署了书面知情同意书。在没有痴呆或中风(平均年龄 56.6 岁;年龄范围 45.7-87.3 岁)且无心脏病临床诊断的人群中,从基于人群的鹿特丹研究中抽取了 2397 名无痴呆或中风的参与者,检测了他们的血清 NT-proBNP 水平。所有参与者均接受了 1.5T MR 成像检查。采用多变量线性和逻辑回归分析,研究 NT-proBNP 水平与无症状性脑损伤的 MR 成像标志物之间的关系,包括容积、局灶和微观结构标志物。
结果 较高的 NT-proBNP 水平与总脑容量较小(NT-proBNP 水平每标准差增加的 z 评分差异,-0.021;95%置信区间[CI]:-0.034,-0.007;P=.003)相关,主要由灰质容量驱动(NT-proBNP 水平每标准差增加的 z 评分差异,-0.037;95%CI:-0.057,-0.017;P<.001)。较高的 NT-proBNP 水平与更大的白质病变体积(NT-proBNP 水平每标准差增加的 z 评分差异,0.090;95%CI:0.051,0.129;P<.001)、更低的各向异性分数(NT-proBNP 水平每标准差增加的 z 评分差异,-0.048;95%CI:-0.088,-0.008;P=.019)和更高的平均弥散度(NT-proBNP 水平每标准差增加的 z 评分差异,0.054;95%CI:0.018,0.091;P=.004)相关。
结论 在社区居住的人群中,较高的血清 NT-proBNP 水平与无症状性脑损伤的容积和微观结构磁共振成像标志物相关。RSNA,2016 在线补充材料可在本文中获取。